ProShare Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Buy |
|
|||||
|
2025
Q1 | $116K | Sell |
|
|||||
|
2024
Q4 | $99.3K | Buy |
|
|||||
|
2024
Q3 | $101K | Buy |
|
|||||
|
2024
Q2 | $117K | Sell |
|
|||||
|
2024
Q1 | $257K | Buy |
|
|||||
|
2023
Q4 | $273K | Buy |
|
|||||
|
2023
Q3 | $222K | Buy |
|
|||||
|
2023
Q2 | $505K | Buy |
|
|||||
|
2023
Q1 | $431K | Sell |
|
|||||
|
2022
Q4 | $443K | Buy |
|
|||||
|
2022
Q3 | $420K | Buy |
|
|||||
|
2022
Q2 | $338K | Buy |
|
|||||
|
2022
Q1 | $202K | Sell |
|
|||||
|
2021
Q4 | $353K | Sell |
|
|||||
|
2021
Q3 | $557K | Buy |
|
|||||
|
2021
Q2 | $597K | Buy |
|
|||||
|
2021
Q1 | $605K | Buy |
|
|||||
|
2020
Q4 | $695K | Sell |
|
|||||
|
2020
Q3 | $511K | Sell |
|
|||||
|
2020
Q2 | $380K | Buy |
|
|||||
|
2020
Q1 | $232K | Sell |
|
|||||
|
2019
Q4 | $898K | Sell |
|
|||||
|
2019
Q3 | $2.13M | Sell |
|
|||||
|
2019
Q2 | $2.96M | Sell |
|
|||||
|
2019
Q1 | $3.07M | Buy |
|
|||||
|
2018
Q4 | $1.65M | Sell |
|
|||||
|
2018
Q3 | $2.92M | Buy |
|
|||||
|
2018
Q2 | $3.06M | Sell |
|
|||||
|
2018
Q1 | $4.28M | Sell |
|
|||||
|
2017
Q4 | $4.62M | Buy |
|
|||||
|
2017
Q3 | $1.46M | Buy |
|
|||||
|
2017
Q2 | $1.77M | Sell |
|
|||||
|
2017
Q1 | $1.66M | Sell |
|
|||||
|
2016
Q4 | $1.5M | Buy |
|
|||||
|
2016
Q3 | $1.07M | Sell |
|
|||||
|
2016
Q2 | $817K | Buy |
|
|||||
|
2016
Q1 | $821K | Buy |
|
|||||
|
2015
Q4 | $1.47M | Buy |
|
|||||
|
2015
Q3 | $986K | Sell |
|
|||||
|
2015
Q2 | $1.78M | Buy |
|
|||||
|
2015
Q1 | $1.09M | Buy |
|
|||||
|
2014
Q4 | $670K | Buy |
|